Technology Core

Information

  • Research Project
  • 9455139
  • ApplicationId
    9455139
  • Core Project Number
    U19AI135976
  • Full Project Number
    1U19AI135976-01
  • Serial Number
    135976
  • FOA Number
    RFA-AI-16-080
  • Sub Project Id
    6319
  • Project Start Date
    2/12/2018 - 7 years ago
  • Project End Date
    1/31/2023 - 2 years ago
  • Program Officer Name
  • Budget Start Date
    6/1/2018 - 6 years ago
  • Budget End Date
    5/31/2019 - 5 years ago
  • Fiscal Year
    2018
  • Support Year
    01
  • Suffix
  • Award Notice Date
    2/12/2018 - 7 years ago

Technology Core

Abstract - Technology Core This U19 proposes a novel and fully integrated approach to understanding disease progression and treatment response in tuberculosis (TB). We will combine traditional approaches to understanding the pathophysiology of TB, bacterial genetics and immunology, with systems biology approaches including genomics, transcriptomics, metabolomics, lipidomics, proteomics, and computational modeling. We will apply HTP ?Omics? technologies and systems analysis to murine and mycobacterial studies and to human field studies in tuberculosis. Data generated by HTP and targeted state-of-the-art approaches will be integrated through bioinformatic and modeling approaches, which, combined with domain expertise, will lead to a deep understanding of the molecular networks that underlie the progression of TB infection and response to treatment, and predict complex biological behaviors that lead to either containment or active disease; treatment cure or relapse. Multiple innovative HTP technologies will be leveraged and enhanced through this program. These technologies have been established in multiple experimental systems and will be customized and further developed for their application to this program and to clinical samples as appropriate. These developments will ensure data quality, and maximize the efficiency of data generation. The approaches chosen are innovative and state-of-the-art and will maximize our ability to complement and extend the existing comprehensive network models and provide spatial perspective for models generated as part of the original OTB program. We will disseminate modifications and improvements to extant technologies and detailed protocols broadly to enable adoption and further development by the community.

IC Name
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
  • Activity
    U19
  • Administering IC
    AI
  • Application Type
    1
  • Direct Cost Amount
    350232
  • Indirect Cost Amount
    48000
  • Total Cost
  • Sub Project Total Cost
    398232
  • ARRA Funded
    False
  • CFDA Code
  • Ed Inst. Type
  • Funding ICs
    NIAID:398232\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    ZAI1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    SEATTLE BIOMEDICAL RESEARCH INSTITUTE
  • Organization Department
  • Organization DUNS
    070967955
  • Organization City
    SEATTLE
  • Organization State
    WA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    981095240
  • Organization District
    UNITED STATES